Clinical Trials Directory

Trials / Conditions / Influenza A Virus, H1N1 Subtype

Influenza A Virus, H1N1 Subtype

6 registered clinical trials studyying Influenza A Virus, H1N1 Subtype.

StatusTrialSponsorPhase
CompletedStudy of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
NCT01053143
Sanofi Pasteur, a Sanofi CompanyPhase 3
UnknownA Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
NCT01053533
Beijing Ditan HospitalN/A
CompletedEvaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
NCT01016548
University Health Network, TorontoPhase 3
CompletedCrossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo
NCT00989404
GlaxoSmithKlinePhase 1
CompletedStudy of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pand
NCT01063608
Institut National de la Santé Et de la Recherche Médicale, FrancePhase 4
CompletedVRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza V
NCT00973895
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1